Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Zijun Y. Xu-Monette, Bouthaina S. Dabaja, Xiaoxiao Wang, Meifeng Tu, Ganiraju C. Manyam, Alexander Tzankov, Yi Xia, Li Zhang, Ruifang Sun, Carlo Visco, Karen Dybkaer, Lihui Yin, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han Van KriekenJooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Michael B. Møller, Ben M. Parsons, Xiaoying Zhao, Jane N. Winter, Miguel A. Piris, Timothy J. McDonnell, Roberto N. Miranda, Yong Li, L. Jeffrey Medeiros, Ken H. Young

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP'. Together they form a unique fingerprint.

Medicine & Life Sciences